Human derived FSH
DrugCustomized for each patient
Other names: Bravelle
NCT Number: NCT00680238
Objective: To compare pregnancy rates and implantation rates when embryos are selected based on a single Day 3 (D.3) score vs. a GES score plus sHLA-G expression.
Looking for future studies?
Notify Me25 year–40 year
Female
Interventional
Not applicable
Comparing pregnancy rates and implantation rates when embryos are selected using the most common criteria for embryo selection on day 3 - the morphology-(number of blastomere, their shape and size and the percentage of fragmentation)vs a graduated embryo score accumulated over 72 hours and the expression of sHLA-G at 44-46 hours post fertilization.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Customized for each patient
Other names: Bravelle
Time frame: 12 weeks
Time frame: 9 months
Time frame: 9-11 day until βhCG
University of Stellenbosch
Other
Pregnancy and Implantation Rates When Embryos Are Selected Based on a Single Day 3 Score (Day 3)vs Graduated Embryo Score(GES) Plus Soluble Human Leukocyte Antigen-G Expression.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05290051
Abortion, Spontaneous, Congenital Abnormalities
Paris, France
View Trial DetailsNCT04156126
Abortion, Spontaneous, Female Urogenital Diseases and Pregnancy Complications
Rochester, Minnesota, United States
View Trial DetailsNCT01363596
Abortion, Spontaneous, Female Urogenital Diseases and Pregnancy Complications
Baton Rouge, Louisiana, United States
View Trial DetailsNCT03218878
Abortion, Spontaneous, Female Urogenital Diseases and Pregnancy Complications
Basking Ridge, New Jersey, United States
View Trial Details